ScholarLens Back to search
2008•ORBi (University of Liège)Open access

Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) on bone remodeling over one year in patients with glucocorticoid-induced osteoporosis

K. Saag, Jean‐Pierre Devogelaer, Donald Malcolm Reid, Philip N. Sambrook, Stefan Goemaere, Sophia Ish‐Shalom, Julien Collette, P. Papanastasiou, A. Ferreira, Erik Fink Eriksen, T. Fashola, Oliver Schönborn‐Kellenberger, Daniel Chappard, Jean‐Yves Reginster

Open full text 0 citations

Abstract

peer reviewed

Open-access reader

About this research paper

What this paper is about

peer reviewed

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

peer reviewed

Key concepts: Medicine, Zoledronic acid, Osteoporosis, Etidronic acid, Glucocorticoid, Bone remodeling, Bone Density Conservation Agents, Diphosphonates

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) on bone remodeling over one year in patients with glucocorticoid-induced osteoporosis — Research Paper | ScholarLens